Monitoring stimulant-medication effects in adults with attention deficit disorder with hyperactivity with AQT processing speed: A commentary
Abstract
This commentary introduces research on monitoring the effects of stimulant medication in 40 adults with ADHD. A Quick Test of Cognitive Speed (AQT) measured the effects of standard low- and high-dose immediate-release methylphenidate within a short time period. Results identified 33 responders and 7 non-responders. For responders, single-dimension (color and form) and dual-dimension (color-form) naming speed increased significantly with high-dose medication and performance profiles were normalized compared to neuro-typical adults. Findings validated prior research and suggested that the procedure and AQT measures might identify the dose point at which normalization occurs after a medication dose has been increased.
Full Text:
PDFReferences
Nielsen NP, Wiig EH, Bäck S, Gustafsson J (2017) Processing speed can monitor stimulant-medication effects in adults with attention deficit disorder with hyperactivity. Nordic J Psyhiat. 71: 296-303.
Wiig EH, Nielsen NP, Minthon L, Warkentin S (2005) A Quick Test of Cognitive Speed. Et kort manual. Svensk versjon & Norsk versjon. Stockholm, Sweden: Harcourt/PsychCorp.
Wiig EH, Nielsen NP, Minthon L (2017) A Quick Test of Cognitive Speed (AQT). Manual and app for ADHD. Copenhagen, Denmark: AQT Assessment ApS.
Wiig EH, Nielsen NP, Jacobson J (2007) A quick test of cognitive speed: group patterns of aging from 15 to 85. Percept Mot Skills. 104:1067-75.
Nielsen NP, Wiig EH (2011) An additive model for relations between AQT single- and dual-dimension naming speed. Percept & Mot Skills 112:499-508.
Nielsen NP, Wiig EH (2011) AQT cognitive speed differentiates adults with and without ADHD: A preliminary study. Int J Psychiatry Clin Pract 15:187-193.
Wiig EH, Nielsen NP (2012) A Quick Test of Cognitive Speed for comparing processing speed and efficiency to differentiate adolescent and adult psychiatric referrals with and without attention-deficit/hyperactivity disorders. Prim Care Companion CNS Disord. 14(2): doi: 10.4088/PCC.11m0127.
Nielsen NP, Wiig EH (2013) Validation of the AQT color-form additive model for screening and monitoring pharmacological treatment of ADHD. J Atten Dis 17: 187-193.
Advokat C (2010) What are cognitive effects of stimulant medication? Emphasis on adults with attention deficit/hyperactivity disorders (ADHD). Neurosci Biobehav Rev. 34:1256-66.
Nielsen NP (2017) Dosis titration with AQT: Evaluating the treatment effect of methylphenidate on adults with ADHD. Conference presentation. MEDICE Arzneimittel Pütter GmbH & Co KG, Berlin.
DOI: http://dx.doi.org/10.18103/imr.v3i11.608
Refbacks
- There are currently no refbacks.